Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Neisseria meningitidis Infections Drug market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Neisseria meningitidis Infections Drugmarket, defines the market attractiveness level of Neisseria meningitidis Infections Drug market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Neisseria meningitidis Infections Drug industry, describes the types of Neisseria meningitidis Infections Drug market, the applications of major players and the market size, and deeply analyzes the current situation of the global Neisseria meningitidis Infections Drug market and the development prospects and opportunities of Neisseria meningitidis Infections Drug industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Neisseria meningitidis Infections Drug market in Chapter 13.
By Player:
Sanofi Pasteur SA
Beijing Minhai Biotechnology Co Ltd
Griffith University
GlaxoSmithKline Plc
JN-International Medical Corp
MGB Biopharma Ltd
Wellstat Vaccines LLC
Serum Institute of India Ltd
ImmunoBiology Ltd
Pfizer Inc
Biological E Ltd
Panacea Biotec Ltd
China National Pharmaceutical Group Corp
By Type:
MGBBP-3
NCL-195
TP-10
Others
By End-User:
Hospital
Clinic
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Neisseria meningitidis Infections Drug Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Neisseria meningitidis Infections Drug Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Neisseria meningitidis Infections Drug Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Neisseria meningitidis Infections Drug Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Neisseria meningitidis Infections Drug Market Analysis and Outlook to 2022
-
7.1 Global Neisseria meningitidis Infections Drug Consumption (2017-2022)
-
7.2 United States Neisseria meningitidis Infections Drug Consumption (2017-2022)
-
7.3 Europe Neisseria meningitidis Infections Drug Consumption (2017-2022)
-
7.4 China Neisseria meningitidis Infections Drug Consumption (2017-2022)
-
7.5 Japan Neisseria meningitidis Infections Drug Consumption (2017-2022)
-
7.6 India Neisseria meningitidis Infections Drug Consumption (2017-2022)
-
7.7 South Korea Neisseria meningitidis Infections Drug Consumption (2017-2022)
8 Region and Country-wise Neisseria meningitidis Infections Drug Market Analysis and Outlook to 2028
-
8.1 Global Neisseria meningitidis Infections Drug Consumption Forecast (2022-2028)
-
8.2 United States Neisseria meningitidis Infections Drug Consumption Forecast (2022-2028)
-
8.3 Europe Neisseria meningitidis Infections Drug Consumption Forecast (2022-2028)
-
8.4 China Neisseria meningitidis Infections Drug Consumption Forecast (2022-2028)
-
8.5 Japan Neisseria meningitidis Infections Drug Consumption Forecast (2022-2028)
-
8.6 India Neisseria meningitidis Infections Drug Consumption Forecast (2022-2028)
-
8.7 South Korea Neisseria meningitidis Infections Drug Consumption Forecast (2022-2028)
9 Global Neisseria meningitidis Infections Drug Market Outlook by Types and Applications to 2022
-
9.1 Global Neisseria meningitidis Infections Drug Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global MGBBP-3 Consumption and Growth Rate (2017-2022)
-
9.1.2 Global NCL-195 Consumption and Growth Rate (2017-2022)
-
9.1.3 Global TP-10 Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Neisseria meningitidis Infections Drug Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Clinic Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Others Consumption and Growth Rate (2017-2022)
10 Global Neisseria meningitidis Infections Drug Market Outlook by Types and Applications to 2028
-
10.1 Global Neisseria meningitidis Infections Drug Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global MGBBP-3 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global NCL-195 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global TP-10 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Neisseria meningitidis Infections Drug Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Clinic Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global Neisseria meningitidis Infections Drug Import and Export Analysis (Top 5 Countries)
-
11.1 Global Neisseria meningitidis Infections Drug Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Neisseria meningitidis Infections Drug Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Neisseria meningitidis Infections Drug Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Neisseria meningitidis Infections Drug Market Competitive Analysis
-
14.1 Sanofi Pasteur SA
-
14.1.1 Sanofi Pasteur SA Company Details
-
14.1.2 Sanofi Pasteur SA Neisseria meningitidis Infections Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Sanofi Pasteur SA Neisseria meningitidis Infections Drug Product and Service
-
14.2 Beijing Minhai Biotechnology Co Ltd
-
14.2.1 Beijing Minhai Biotechnology Co Ltd Company Details
-
14.2.2 Beijing Minhai Biotechnology Co Ltd Neisseria meningitidis Infections Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Beijing Minhai Biotechnology Co Ltd Neisseria meningitidis Infections Drug Product and Service
-
14.3 Griffith University
-
14.3.1 Griffith University Company Details
-
14.3.2 Griffith University Neisseria meningitidis Infections Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Griffith University Neisseria meningitidis Infections Drug Product and Service
-
14.4 GlaxoSmithKline Plc
-
14.4.1 GlaxoSmithKline Plc Company Details
-
14.4.2 GlaxoSmithKline Plc Neisseria meningitidis Infections Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 GlaxoSmithKline Plc Neisseria meningitidis Infections Drug Product and Service
-
14.5 JN-International Medical Corp
-
14.5.1 JN-International Medical Corp Company Details
-
14.5.2 JN-International Medical Corp Neisseria meningitidis Infections Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 JN-International Medical Corp Neisseria meningitidis Infections Drug Product and Service
-
14.6 MGB Biopharma Ltd
-
14.6.1 MGB Biopharma Ltd Company Details
-
14.6.2 MGB Biopharma Ltd Neisseria meningitidis Infections Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 MGB Biopharma Ltd Neisseria meningitidis Infections Drug Product and Service
-
14.7 Wellstat Vaccines LLC
-
14.7.1 Wellstat Vaccines LLC Company Details
-
14.7.2 Wellstat Vaccines LLC Neisseria meningitidis Infections Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Wellstat Vaccines LLC Neisseria meningitidis Infections Drug Product and Service
-
14.8 Serum Institute of India Ltd
-
14.8.1 Serum Institute of India Ltd Company Details
-
14.8.2 Serum Institute of India Ltd Neisseria meningitidis Infections Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Serum Institute of India Ltd Neisseria meningitidis Infections Drug Product and Service
-
14.9 ImmunoBiology Ltd
-
14.9.1 ImmunoBiology Ltd Company Details
-
14.9.2 ImmunoBiology Ltd Neisseria meningitidis Infections Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 ImmunoBiology Ltd Neisseria meningitidis Infections Drug Product and Service
-
14.10 Pfizer Inc
-
14.10.1 Pfizer Inc Company Details
-
14.10.2 Pfizer Inc Neisseria meningitidis Infections Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Pfizer Inc Neisseria meningitidis Infections Drug Product and Service
-
14.11 Biological E Ltd
-
14.11.1 Biological E Ltd Company Details
-
14.11.2 Biological E Ltd Neisseria meningitidis Infections Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 Biological E Ltd Neisseria meningitidis Infections Drug Product and Service
-
14.12 Panacea Biotec Ltd
-
14.12.1 Panacea Biotec Ltd Company Details
-
14.12.2 Panacea Biotec Ltd Neisseria meningitidis Infections Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.12.3 Panacea Biotec Ltd Neisseria meningitidis Infections Drug Product and Service
-
14.13 China National Pharmaceutical Group Corp
-
14.13.1 China National Pharmaceutical Group Corp Company Details
-
14.13.2 China National Pharmaceutical Group Corp Neisseria meningitidis Infections Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.13.3 China National Pharmaceutical Group Corp Neisseria meningitidis Infections Drug Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Neisseria meningitidis Infections Drug
-
Figure Neisseria meningitidis Infections Drug Picture
-
Table Global Neisseria meningitidis Infections Drug Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Neisseria meningitidis Infections Drug Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Neisseria meningitidis Infections Drug Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Neisseria meningitidis Infections Drug Consumption by Country (2017-2022)
-
Figure United States Neisseria meningitidis Infections Drug Consumption and Growth Rate (2017-2022)
-
Table Europe Neisseria meningitidis Infections Drug Consumption and Growth Rate (2017-2022)
-
Figure China Neisseria meningitidis Infections Drug Consumption and Growth Rate (2017-2022)
-
Figure Japan Neisseria meningitidis Infections Drug Consumption and Growth Rate (2017-2022)
-
Figure India Neisseria meningitidis Infections Drug Consumption and Growth Rate (2017-2022)
-
Figure South Korea Neisseria meningitidis Infections Drug Consumption and Growth Rate (2017-2022)
-
Figure Global Neisseria meningitidis Infections Drug Consumption Forecast by Country (2022-2028)
-
Figure United States Neisseria meningitidis Infections Drug Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Neisseria meningitidis Infections Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Neisseria meningitidis Infections Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Neisseria meningitidis Infections Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Neisseria meningitidis Infections Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Neisseria meningitidis Infections Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global MGBBP-3 Consumption and Growth Rate (2017-2022)
-
Figure Global NCL-195 Consumption and Growth Rate (2017-2022)
-
Figure Global TP-10 Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Consumption and Growth Rate (2017-2022)
-
Figure Global Clinic Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global MGBBP-3 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global NCL-195 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global TP-10 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Neisseria meningitidis Infections Drug Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Neisseria meningitidis Infections Drug Export by Region (Top 5 Countries) (2017-2028)
-
Table Sanofi Pasteur SA (Foundation Year, Company Profile and etc.)
-
Table Sanofi Pasteur SA Neisseria meningitidis Infections Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi Pasteur SA Neisseria meningitidis Infections Drug Product and Service
-
Table Beijing Minhai Biotechnology Co Ltd (Foundation Year, Company Profile and etc.)
-
Table Beijing Minhai Biotechnology Co Ltd Neisseria meningitidis Infections Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Beijing Minhai Biotechnology Co Ltd Neisseria meningitidis Infections Drug Product and Service
-
Table Griffith University (Foundation Year, Company Profile and etc.)
-
Table Griffith University Neisseria meningitidis Infections Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Griffith University Neisseria meningitidis Infections Drug Product and Service
-
Table GlaxoSmithKline Plc (Foundation Year, Company Profile and etc.)
-
Table GlaxoSmithKline Plc Neisseria meningitidis Infections Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline Plc Neisseria meningitidis Infections Drug Product and Service
-
Table JN-International Medical Corp (Foundation Year, Company Profile and etc.)
-
Table JN-International Medical Corp Neisseria meningitidis Infections Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table JN-International Medical Corp Neisseria meningitidis Infections Drug Product and Service
-
Table MGB Biopharma Ltd (Foundation Year, Company Profile and etc.)
-
Table MGB Biopharma Ltd Neisseria meningitidis Infections Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table MGB Biopharma Ltd Neisseria meningitidis Infections Drug Product and Service
-
Table Wellstat Vaccines LLC (Foundation Year, Company Profile and etc.)
-
Table Wellstat Vaccines LLC Neisseria meningitidis Infections Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Wellstat Vaccines LLC Neisseria meningitidis Infections Drug Product and Service
-
Table Serum Institute of India Ltd (Foundation Year, Company Profile and etc.)
-
Table Serum Institute of India Ltd Neisseria meningitidis Infections Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Serum Institute of India Ltd Neisseria meningitidis Infections Drug Product and Service
-
Table ImmunoBiology Ltd (Foundation Year, Company Profile and etc.)
-
Table ImmunoBiology Ltd Neisseria meningitidis Infections Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table ImmunoBiology Ltd Neisseria meningitidis Infections Drug Product and Service
-
Table Pfizer Inc (Foundation Year, Company Profile and etc.)
-
Table Pfizer Inc Neisseria meningitidis Infections Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Inc Neisseria meningitidis Infections Drug Product and Service
-
Table Biological E Ltd (Foundation Year, Company Profile and etc.)
-
Table Biological E Ltd Neisseria meningitidis Infections Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Biological E Ltd Neisseria meningitidis Infections Drug Product and Service
-
Table Panacea Biotec Ltd (Foundation Year, Company Profile and etc.)
-
Table Panacea Biotec Ltd Neisseria meningitidis Infections Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Panacea Biotec Ltd Neisseria meningitidis Infections Drug Product and Service
-
Table China National Pharmaceutical Group Corp (Foundation Year, Company Profile and etc.)
-
Table China National Pharmaceutical Group Corp Neisseria meningitidis Infections Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table China National Pharmaceutical Group Corp Neisseria meningitidis Infections Drug Product and Service
-
